<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T05:27:51Z</responseDate>
  <request identifier="oai:figshare.com:article/32641905" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32641905</identifier>
        <datestamp>2026-10-01T16:19:50Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Molecular cloning, synthesis and bioactivity study of a bioactive peptide from the skin secretion of the Burmeister's leaf frog, &lt;i&gt;Phyllomedusa burmeisteri&lt;/i&gt;</dc:title>
          <dc:creator>Chenyu Liao (18135052)</dc:creator>
          <dc:subject>PUREID: 658701105</dc:subject>
          <dc:subject>Antimicrobial peptides</dc:subject>
          <dc:subject>anticancer peptides</dc:subject>
          <dc:subject>haemolysis</dc:subject>
          <dc:subject>HPLC</dc:subject>
          <dc:subject>mass spectrometry</dc:subject>
          <dc:subject>molecular cloning</dc:subject>
          <dc:description>Antibiotic resistance is a growing global health threat, highlighting the urgent need for novel antimicrobial agents. This study investigated the antimicrobial, anticancer, and toxicity properties of a bioactive peptide, QUB-1962, a phylloseptin-family peptide derived from the skin secretion of Burmeister's leaf frog, (Phyllomedusa burmeisteri), with a focus on its potential therapeutic applications. The peptide was first identified via molecular cloning, then synthesised by solid-phase peptide synthesis, and subsequently purified and characterised by HPLC and mass spectrometry. Its bioactivity was assessed through antimicrobial assays, haemolysis tests, and cell viability/toxicity assays. QUB-1962 exhibited broad-spectrum antimicrobial activity, showing the strongest efficacy against Staphylococcus aureus with a MIC of 8 μM, while also inhibiting Escherichia coli and Candida albicans. In anticancer assays, the peptide significantly inhibited the proliferation of human lung cancer cells with an IC₅₀ of 26.98 μM; however, it demonstrated a comparable level of cytotoxicity against normal human lung cells, indicating a lack of selectivity. Additionally, it displayed minimal hemolytic activity against horse red blood cells even at high concentrations, with less than 10% hemolysis observed at 100 μM. These results indicate that QUB-1962 has a favourable therapeutic index and represents a promising lead compound for the development of antimicrobial and anticancer therapeutics. Further optimisation and in vivo validation are required to fully establish its therapeutic potential.&lt;br&gt;&lt;br&gt;&lt;i&gt;Thesis is embargoed until 31 December 2030.&lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T16:19:50Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32641905.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Molecular_cloning_synthesis_and_bioactivity_study_of_a_bioactive_peptide_from_the_skin_secretion_of_the_Burmeister_s_leaf_frog_i_Phyllomedusa_burmeisteri_i_/32641905</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2030-12-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
